All In MedTech

FDA Clearance Tracker · P930016-S045

IDESIGN ADVANCED WAVESCAN STUDIO, STAR EXCIMER LASER SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 14, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 14, 2016

Approved

Time to decision

532 days

Received Jun 1, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P930016-S045
Device name
IDESIGN ADVANCED WAVESCAN STUDIO, STAR EXCIMER LASER SYSTEM
Applicant location
Milpitas, CA
Received
Jun 1, 2015
Decided
Nov 14, 2016
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P930016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

Approval for the STAR S4 IR Excimer Laser System and iDesign Advanced WaveScan Studio Indication System is indicated for wavefront-guided laser assisted in situ keratomileusis (LASIK) for Use: in patients:1) with mixed astigmatism as measured by iDesign Advanced WaveScan Studio System where the magnitude of cylinder (1.0 to 5.0 D) is greater than the magnitude of sphere, and the cylinder and sphere have opposite signs; 2) with agreement between manifest refraction (adjusted for optical infinity) and iDesign Advanced WaveScan Studio System refraction as follows:a) Spherical Equivalent: Magnitude of the difference is less than 0.625 D; b)Cylinder: Magnitude of the difference is less than or equal to 0.5 D.; and c) 18 years of age or older, and with refractive stability (a change of <=1.0 D in sphere or cylinder for a minimum of 12 months prior to surgery).

Source documents

Other decisions for Amo Manufacturing USA, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.